DE3785388D1 - Antivirale peptide und mittel zur behandlung von herpes. - Google Patents

Antivirale peptide und mittel zur behandlung von herpes.

Info

Publication number
DE3785388D1
DE3785388D1 DE8787107327T DE3785388T DE3785388D1 DE 3785388 D1 DE3785388 D1 DE 3785388D1 DE 8787107327 T DE8787107327 T DE 8787107327T DE 3785388 T DE3785388 T DE 3785388T DE 3785388 D1 DE3785388 D1 DE 3785388D1
Authority
DE
Germany
Prior art keywords
herpes
agents
treatment
antiviral peptides
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787107327T
Other languages
English (en)
Other versions
DE3785388T2 (de
Inventor
Eric A Cohen
Pierrette Gaudreau
Jacques Michaud
Paul Brauzeau
Yves Langelier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 530250 external-priority patent/CA1277901C/en
Application filed by Individual filed Critical Individual
Publication of DE3785388D1 publication Critical patent/DE3785388D1/de
Application granted granted Critical
Publication of DE3785388T2 publication Critical patent/DE3785388T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8787107327T 1986-05-20 1987-05-20 Antivirale peptide und mittel zur behandlung von herpes. Expired - Fee Related DE3785388T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA509527 1986-05-20
CA 530250 CA1277901C (en) 1987-02-20 1987-02-20 Means for treating herpes infections

Publications (2)

Publication Number Publication Date
DE3785388D1 true DE3785388D1 (de) 1993-05-19
DE3785388T2 DE3785388T2 (de) 1993-09-02

Family

ID=25671005

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787107327T Expired - Fee Related DE3785388T2 (de) 1986-05-20 1987-05-20 Antivirale peptide und mittel zur behandlung von herpes.

Country Status (6)

Country Link
US (1) US4795740A (de)
EP (1) EP0246630B1 (de)
AU (1) AU602334B2 (de)
DE (1) DE3785388T2 (de)
ES (1) ES2054630T3 (de)
NZ (1) NZ220365A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (de) * 1987-05-22 1990-08-22 Merck & Co. Inc. Hemmungsstoff für Ribonukleotid-Reduktase
FR2620938B3 (fr) * 1987-09-30 1990-01-05 Bontemps Raymond Nouveau dispositif destine a conserver des substances cosmetiques congelables
CA1302887C (en) * 1987-11-24 1992-06-09 Yves Langelier Combination of acyclovir or a derivative thereof and bacitracin
CA1327869C (en) * 1989-02-17 1994-03-15 Yvan Guindon Ribonucleotide reductase inhibitors
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
CA1340683C (en) * 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides having a substituted aspartic acid side chain
CA1340681C (en) * 1989-07-07 1999-07-27 Robert Deziel Antiherpes tetrapeptides having a substituted aspartic acid side chain
CA1340684C (en) * 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides
EP0411333B1 (de) * 1989-07-07 1995-05-31 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes-Tetrapeptid-Derivate mit einer substituierten Seitenkette aus Asparaginsäure
DE69017113T2 (de) * 1989-07-07 1995-08-03 Bio Mega Boehringer Ingelheim Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten.
US5110799A (en) * 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
US5648337A (en) * 1990-07-03 1997-07-15 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptides
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
SG42995A1 (en) 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
US5574015A (en) * 1992-03-12 1996-11-12 Bio-Mega/Boehringer Ingelheim Research Inc. Isosteric antiherpes peptide derivatives
IT1280157B1 (it) * 1995-04-12 1998-01-05 Consorzio Di Ricerche Biomedic Procedimento per la preparazione e la conservazione di colture cellulari, o di parti di cellule, allo stato pronto per dosaggi
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
JP2002505917A (ja) * 1998-03-12 2002-02-26 ザ、プロクター、エンド、ギャンブル、カンパニー 吸収性物品中のプロテアーゼインヒビタ
EP1862471A3 (de) * 2000-02-07 2008-05-28 Wisconsin Alumni Research Foundation Pharmakologisch aktive antivirale Peptide und Verfahren zu ihrer Verwendung
ES2293977T3 (es) * 2000-02-07 2008-04-01 Wisconsin Alumni Research Foundation Peptidos antivirales farmacologicamente activos y metodo para su uso.
DE60221705T2 (de) * 2001-03-22 2008-06-05 The United States of America, represented by the Secretary, Dept. of Health and Human Services, the Natl. Institutes of Health, Office of Technology Transfer Glykosylierungsresistente cyanovirine und damit verbundene konjugate, zusammensetzungen, nukleinsäuren, vektoren, wirtszellen, herstellungsverfahren sowie verfahren zur verwendung nichtglykosylierter cyanovirine
WO2003051835A2 (en) * 2001-12-18 2003-06-26 Proteologics, Inc. Methods and compositions for the inhibition of viral release
WO2005060541A2 (en) * 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection
PL227562B1 (pl) 2011-09-23 2017-12-29 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB185024A (en) * 1921-09-02 1922-08-31 Singer Mfg Co Motor driven sewing machine
US4126606A (en) * 1976-10-04 1978-11-21 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Physiologically active peptides and a process for preparation thereof
GB2062643B (en) * 1979-11-07 1983-04-07 Mckerns K W Contraceptive polypeptides
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
IL65184A (en) * 1982-03-05 1985-08-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
DE3514587A1 (de) * 1985-04-23 1986-10-30 Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl Pharmakologisch aktive peptide
IE870507L (en) * 1986-03-07 1987-09-07 Biothechnological Res Partners Bovine virus diarrhea and hog cholera vaccines

Also Published As

Publication number Publication date
EP0246630A2 (de) 1987-11-25
US4795740A (en) 1989-01-03
NZ220365A (en) 1990-06-26
EP0246630A3 (en) 1989-01-04
AU602334B2 (en) 1990-10-11
AU7321087A (en) 1987-11-26
ES2054630T3 (es) 1994-08-16
DE3785388T2 (de) 1993-09-02
EP0246630B1 (de) 1993-04-14

Similar Documents

Publication Publication Date Title
DE3785388D1 (de) Antivirale peptide und mittel zur behandlung von herpes.
DE3688296D1 (de) Arzneimittel zur behandlung von erbrechen.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3777861D1 (de) Behandlung von gasen.
DE3751576T2 (de) Virale Inaktivierung und Reinigung von aktiven Proteinen.
IT8767994A0 (it) Procedimento e impianto per la denaturazione di vernici
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE3852625D1 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE88189T1 (de) Antivirale peptide und mittel zur behandlung von herpes.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE3855561T2 (de) Mittel zur verhütung von zahnbelag und belagabhängigen krankheiten
DE68904322T2 (de) Einrichtung zur behandlung von gasen.
ATE74537T1 (de) Behandlung von gebrauchten antimonhalidkatalysatoren.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE59813114D1 (de) BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrangungen
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
ATE81454T1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
ZA869678B (en) Use of oligopeptides in the treatment of viral infections
ATE104850T1 (de) Naphtochinone zur behandlung und prophylaxe von pneumocystis carinii-infektionen.
DE68906794T2 (de) Zubereitungen zur behandlung von leishmaniasis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee